QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
NASDAQ:VRCA

Verrica Pharmaceuticals (VRCA) Earnings Date, Estimates & Call Transcripts

$5.70
+0.03 (+0.53%)
(As of 06/1/2023 ET)
Compare
Today's Range
$5.61
▼
$5.85
50-Day Range
$5.32
▼
$6.79
52-Week Range
$1.78
▼
$8.69
Volume
110,861 shs
Average Volume
174,462 shs
Market Capitalization
$239.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(May. 9)
-$0.15 Beat By $0.05
Consensus EPS
(May. 9)
-$0.20
Last Year's Q2 EPS
(5/9/2022)
-$0.30
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

VRCA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VRCA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Verrica Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.22)($0.19)($0.20)
Q2 20233($0.28)($0.21)($0.24)
Q3 20233($0.43)($0.16)($0.29)
Q4 20233($0.41)($0.09)($0.30)
FY 202312($1.34)($0.65)($1.04)

VRCA Earnings Date and Information

Verrica Pharmaceuticals last announced its quarterly earnings results on May 9th, 2023. The reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.05. The business had revenue of $0.04 million for the quarter. Verrica Pharmaceuticals has generated ($0.66) earnings per share over the last year (($0.66) diluted earnings per share). Earnings for Verrica Pharmaceuticals are expected to grow in the coming year, from ($1.00) to ($0.87) per share. Verrica Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

Verrica Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)		        
5/9/2023Q1 2023($0.20)($0.15)+$0.05($0.15)$0.04 million
3/6/202312/31/2022($0.19)($0.14)+$0.05($0.14)$0.07 million
11/7/2022Q3 2022($0.11)$0.03+$0.14$0.06$8.00 million$8.32 million
8/11/2022Q2 2022($0.36)($0.36)($0.35)$0.21 million
5/9/2022Q1 2022($0.59)($0.30)+$0.29($0.29)$0.43 million
3/2/2022Q4 2021($0.48)($0.35)+$0.13($0.35)
11/12/20219/30/2021($0.51)($0.47)+$0.04($0.45)
8/10/20216/30/2021($0.41)($0.43)($0.02)($0.43)
5/7/2021Q1 2021($0.35)($0.04)+$0.31($0.04)$12.00 million
3/3/202112/31/2020($0.42)($0.52)($0.10)($0.52)
11/9/20209/30/2020($0.43)($0.42)+$0.01($0.42)
8/5/20206/30/2020($0.45)($0.38)+$0.07($0.38)
5/7/20203/31/2020($0.38)($0.39)($0.01)($0.39)
3/13/202012/31/2019($0.30)($0.31)($0.01)($0.31)
11/6/2019Q3($0.27)($0.24)+$0.03($0.24)
8/7/2019Q2 2019($0.30)($0.28)+$0.02($0.28)
5/7/2019Q1($0.2850)($0.30)($0.0150)($0.30)
3/7/2019Q4($0.2730)($0.30)($0.0270)($0.30)
11/7/2018Q3($0.2450)($0.27)($0.0250)($0.27)
8/7/2018Q2 2018($0.28)($1.04)($0.76)($1.04)












Verrica Pharmaceuticals Earnings - Frequently Asked Questions

When is Verrica Pharmaceuticals's earnings date?

Verrica Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on VRCA's earnings history.

Did Verrica Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.05. Learn more on analysts' earnings estimate vs. VRCA's actual earnings.

How much revenue does Verrica Pharmaceuticals generate each year?

Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded annual revenue of $9.03 million.

How much profit does Verrica Pharmaceuticals generate each year?

Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded net income of -$24.49 million. VRCA has generated -$0.66 earnings per share over the last four quarters.

What is Verrica Pharmaceuticals's EPS forecast for next year?

Verrica Pharmaceuticals's earnings are expected to grow from ($1.00) per share to ($0.87) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:VRCA) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -